News

ProteoNic, a leader in premium vector technology for biologics and cell and gene therapy, today announced the launch of its ...
Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing ...
This year, headlines in the cell and gene therapy landscape have so far been dominated by Sarepta. The biotech’s Duchenne ...
CRISPR gene-edited cell therapy improves quality of life in patients with transfusion-dependent beta-thalassemia, research suggests.
The therapy, which prevents the degeneration of sensory cells in the ear, has shown greater efficiency than existing approaches, offering hope for a condition that currently has no cure.
In the last few years, Gene and Cell Therapy research has emerged as one of the most promising technologies for treating ...
Demonstrating the clonal origin of therapeutic cell lines is a regulatory requirement for the production of gene therapies ...
Both conditions showed the same quadratic trend in age-adjusted mortality but in opposite directions: declining for CF and ...
The drug, Yescarta, is reportedly sold in Singapore for about S$480,700. Read more at straitstimes.com. Read more at ...
In a significant development for China's burgeoning cell and gene therapy sector, the Chinese Society of Gene and Cell ...